Ovid Therapeutics Inc. (OVID) Free cash flow 2016–2025
Ovid Therapeutics Inc. (OVID) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.3MFY2025 · since FY2016: -$17.8M → -$38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.3M | +31.6% |
| FY2024 | -$56.0M | -22.3% |
| FY2023 | -$45.8M | +18.8% |
| FY2022 | -$56.5M | -147.7% |
| FY2021 | $118.4M | +329.0% |
| FY2020 | -$51.7M | -1.1% |
| FY2019 | -$51.1M | -12.2% |
| FY2018 | -$45.6M | -44.7% |
| FY2017 | -$31.5M | -76.7% |
| FY2016 | -$17.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice